Related references
Note: Only part of the references are listed.High Frequency of IMP-6 among Clinical Isolates of Metallo-β-Lactamase-Producing Escherichia coli in Japan
Hisakazu Yano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Systematic Analysis of Metallo-β-Lactamases Using an Automated Database
Michael Widmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea
Jung Sik Yoo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Epidemiological Expansion, Structural Studies, and Clinical Challenges of New beta-Lactamases from Gram-Negative Bacteria
Karen Bush et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65 (2011)
Analysis of the Functional Contributions of Asn233 in Metallo-β-Lactamase IMP-1
Nicholas G. Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea
Yoonmi Seok et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
Biochemical and Structural Characterization of Mycobacterium tuberculosis β-Lactamase with the Carbapenems Ertapenem and Doripenem
Lee W. Tremblay et al.
BIOCHEMISTRY (2010)
Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Karen Bush
CURRENT OPINION IN MICROBIOLOGY (2010)
Evolving Carbapenemases: Can Medicinal Chemists Advance One Step Ahead of the Coming Storm?
Peter Oelschlaeger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-beta-lactamase in a Korean hospital
Nam Hee Ryoo et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Has the era of untreatable infections arrived?
David M. Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Meropenem - A review of its use in the treatment of serious bacterial infections
Claudine M. Baldwin et al.
DRUGS (2008)
Hydroxyl groups in the ββ sandwich of metallo-β-lactamases favor enzyme activity:: A computational protein design study
P Oelschlaeger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Impact of remote mutations on metallo-β-lactamase substrate specificity:: Implications for the evolution of antibiotic resistance
P Oelschlaeger et al.
PROTEIN SCIENCE (2005)
In vitro evolution predicts that the IMP-1 metallo-β-lactamase does not have the potential to evolve increased activity against imipenem
BG Hall
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Modeling domino effects in enzymes:: Molecular basis of the substrate specificity of the bacterial metallo-β-lactamases IMP-1 and IMP-6
P Oelschlaeger et al.
BIOCHEMISTRY (2003)
Insight into the mechanism of the IMP-1 metallo-β-lactamase by molecular dynamics simulations
P Oelschlaeger et al.
PROTEIN ENGINEERING (2003)
Appropriate empirical antibacterial therapy for nosocmial infections - Getting it right the first time
MH Kollef
DRUGS (2003)
Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)
E Viaene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β-lactamase
JH Toney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem
H Yano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase
S Iyobe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor:: Binding determinants of a potent, broad-spectrum inhibitor
NO Concha et al.
BIOCHEMISTRY (2000)